Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Signing of Definitive Agreement to Acquire Drug Lab 118 (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Bankruptcy is Not Imminent
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by greatplayon Nov 14, 2016 2:46pm
140 Views
Post# 25458441

RE:RE:Bankruptcy is Not Imminent

RE:RE:Bankruptcy is Not ImminentEverything you heard bad was done just for one sake, lure in shorters... before it was opposite... In reality, they got new money $330MLN, means business will be OK, maybe not good, but will continue to make money, last quarter company increases money on hand from 145MLN to 162MLN... not a lot, but it's not a sign of failing company

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities